Article info
PDFClinical and epidemiological research
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis
- D M Lee, Brigham and Women’s Hospital, Rheumatology, Immunology and Allergy, Smith 552B, 1 Jimmy Fund Way, Boston, Massachusetts 02115, USA; dlee1{at}partners.org
Citation
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis
Publication history
- Accepted March 24, 2008
- First published April 7, 2008.
Online issue publication
January 12, 2009
Article Versions
- Previous version (7 April 2008).
- Previous version (21 November 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism